GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...
Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related ...
New studies link GLP-1 drugs like Ozempic and Mounjaro to lower cancer progression and death risk, including breast cancer ...
NSCLC showed the largest reduction in metastatic progression with GLP-1RAs versus gliptins (HR 0.50), with significant ...
Newser on MSN
Weight loss drugs tied to lower cancer progression
Blockbuster weight-loss drugs may be doing more than shrinking waistlines—they could be slowing cancer, too. Four ...
GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective ...
GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers ...
A suite of new studies suggest drugs such as Ozempic and Zepbound might slow tumor progression and improve survival, but more ...
Recently, the research group led by Dr. Dechao Feng, Lecturer at University College London (UCL) and Distinguished Research ...
Treating breast cancer that has begun to spread around the body with targeted radiotherapy could help patients to live longer ...
Merck shares rose after partner Kelun-Biotech reported positive late-stage trial results for a Keytruda combination treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results